lung cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age 75 years or older at the time of obtaining informed consent 2) Scheduled to undergo definitive radiotherapy for non-small cell lung cancer 3) No concurrent or sequential chemotherapy planned 4) No prior radiotherapy involving the hilum or mediastinum, including for other cancer types 5) Able to communicate in Japanese and has provided written informed consent to participate in the study
Exclusion criteria
Exclusion criteria: 1) Presence of active double (synchronous) cancer 2) Any other condition judged by the principal investigator to be inappropriate for study participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients without a decline in instrumental activities of daily living (IADL) at 6 months after radiotherapy | — |
Secondary
| Measure | Time frame |
|---|---|
| TMIG-IADL(changs), EQ-5D-5L(changes), overall survival, recurrence-free survival, cumulative incidence of recurrence, incidence of adverse events | — |
Countries
Japan
Contacts
National Cancer Center Hospital East Radiaiton Oncology